Cancer Research 09 AM Call for Abstracts  SU2C
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
[Cancer Research 65, 10635, November 15, 2005]
© 2005 American Association for Cancer Research


Corrections

Inactivation of Rb and p300/CBP to Bypass Senescence

In the article on inactivation of Rb and p300/CBP to bypass senescence in the September 15, 2005 issue of Cancer Research (1), on page 8301, in the first full paragraph in the left-hand column, Tyr47{gamma}His should have read Tyr47->His, Cys124{gamma}Gly should have read Cys124->Gly, and Arg2{gamma}Gly should have read Arg2->Gly. In that same paragraph, Rb should have read pRb so that the sentence reads "Deletion of residues 2 to 11 ({Delta}2-11) and an Arg2->Gly point mutation (RG2) in the NH2 terminus, as well as {Delta}61 to 85 deletion in CR1, abolished or greatly reduced p300/CBP binding while having little effect on the binding to pRb, p107, and p130 (41)." Panel 3E was also missing from Figure 3. The corrected figure appears below.



View larger version (50K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 5. E1A-mediated bypass of ras-induced premature senescence requires the Rb-binding and p300/CBP-binding activities, but not the p400-binding activity. A, growth curves of BJ cells (PD28) cotransduced with E1A1-143 containing the {Delta}26 to 35 mutation or its vector (BP) and Ha-RasV12 or its vector (WH) were followed over a period of 16 days. Points, mean PDs for duplicates; bars, SD. B, growth curves of BJ cells (PD27) cotransduced with E1A1-143, E1A1-143 containing the 27/124 or RG2 mutation or their vector (BP), and Ha-RasV12 or its vector (WH) were followed over a period of 14 days. Points, mean PDs for duplicates; bars, SD. C, percentage of cells positive for senescence-associated ß-galactosidase were determined in BJ cell populations cotransduced with E1A1-143, E1A1-143 containing the 27/124 or RG2 mutation or their vector (BP), and Ha-RasV12 or its vector (WH) on day 14 postinfection. *P < 0.001 versus BP + BH; **P < 0.0001 versus BP + BH, #P < 0.05 versus BP + BH. D, Rb-binding defective and the p300/CBP-binding defective mutants of E1A complemented each other to rescue ras-induced senescence. Growth curves of BJ cells (PD27) transduced first with the E1A1-143-RG2 mutant or its vector (WN), and then cotransduced with the E1A1-143-27/124 mutant or its vector (BP) and Ha-RasV12 or its vector (WH) were followed over a period of 14 days. Points, mean PDs for duplicates; bars, SD. ##P < 0.005 versus BP-WN-Ras. E, Western blot analysis of BJ cells transduced with wild-type or indicated mutants of E1A1-143 or BP vector and Ha-RasV12 or WH vector, showing protein levels of Ras and E1A.

 
References

  1. Deng Q, Li Y, Tedesco D, Liao R, Fuhrmann G, Sun P. The ability of E1A to rescue ras-induced premature senescence and confer transformation relies on inactivation of both p300/CBP and Rb family proteins. Cancer Res 2005;65:8298–307.[Abstract/Free Full Text]




This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online